Intelligent Bio Solutions Inc. (INBS)

USD 1.36

(0.74%)

Total Assets Summary of Intelligent Bio Solutions Inc.

  • Intelligent Bio Solutions Inc.'s latest annual total assets in 2024 was 13.77 Million USD , up 33.07% from previous year.
  • Intelligent Bio Solutions Inc.'s latest quarterly total assets in 2024 FY was 13.77 Million USD , up 33.07% from previous quarter.
  • Intelligent Bio Solutions Inc. reported annual total assets of 10.35 Million USD in 2023, down -16.17% from previous year.
  • Intelligent Bio Solutions Inc. reported annual total assets of 12.35 Million USD in 2022, down -39.45% from previous year.
  • Intelligent Bio Solutions Inc. reported quarterly total assets of 17.03 Million USD for 2024 Q3, up 93.03% from previous quarter.
  • Intelligent Bio Solutions Inc. reported quarterly total assets of 13.77 Million USD for 2024 FY, up 33.07% from previous quarter.

Annual Total Assets Chart of Intelligent Bio Solutions Inc. (2024 - 2017)

Historical Annual Total Assets of Intelligent Bio Solutions Inc. (2024 - 2017)

Year Total Assets Total Assets Growth
2024 13.77 Million USD 33.07%
2023 10.35 Million USD -16.17%
2022 12.35 Million USD -39.45%
2021 20.4 Million USD 724.05%
2020 2.47 Million USD 6.34%
2019 2.32 Million USD -6.73%
2018 2.49 Million USD 274.07%
2017 667.22 Thousand USD 0.0%

Peer Total Assets Comparison of Intelligent Bio Solutions Inc.

Name Total Assets Total Assets Difference
Aclaris Therapeutics, Inc. 197.4 Million USD 93.02%
Applied DNA Sciences, Inc. 13.65 Million USD -0.932%
Aspira Women's Health Inc. 6.26 Million USD -120.039%
Biodesix, Inc. 99.09 Million USD 86.095%
BioNexus Gene Lab Corp. 11.39 Million USD -20.869%
bioAffinity Technologies, Inc. 8.22 Million USD -67.594%
bioAffinity Technologies, Inc. 8.22 Million USD -67.594%
Bionano Genomics, Inc. 214.4 Million USD 93.573%
CareDx, Inc 484.61 Million USD 97.157%
Check-Cap Ltd. 25.01 Million USD 44.922%
Castle Biosciences, Inc. 477.81 Million USD 97.116%
DarioHealth Corp. 96.38 Million USD 85.705%
Exact Sciences Corporation 6.47 Billion USD 99.787%
Fulgent Genetics, Inc. 1.27 Billion USD 98.918%
Guardant Health, Inc. 1.78 Billion USD 99.229%
ICON Public Limited Company 16.98 Billion USD 99.919%
IDEXX Laboratories, Inc. 3.25 Billion USD 99.577%
Illumina, Inc. 10.11 Billion USD 99.864%
iSpecimen Inc. 15.81 Million USD 12.898%
Standard BioTools Inc. 323.06 Million USD 95.735%
MDxHealth SA 129.13 Million USD 89.33%
23andMe Holding Co. 395.16 Million USD 96.513%
Medpace Holdings, Inc. 1.65 Billion USD 99.168%
Myriad Genetics, Inc. 1.19 Billion USD 98.851%
Mainz Biomed B.V. 15.4 Million USD 10.579%
ENDRA Life Sciences Inc. 6.75 Million USD -104.006%
NeoGenomics, Inc. 1.68 Billion USD 99.18%
Neogen Corporation 4.58 Billion USD 99.699%
Inotiv, Inc. 856.53 Million USD 98.391%
Natera, Inc. 1.45 Billion USD 99.054%
OPKO Health, Inc. 2.01 Billion USD 99.315%
Psychemedics Corporation 13.27 Million USD -3.835%
Prenetics Global Limited 254.17 Million USD 94.579%
Prenetics Global Limited 254.17 Million USD 94.579%
Precipio, Inc. 18.1 Million USD 23.878%
Personalis, Inc. 225.09 Million USD 93.879%
RadNet, Inc. 2.88 Billion USD 99.523%
Sera Prognostics, Inc. 95.44 Million USD 85.563%
Sotera Health Company 3.13 Billion USD 99.56%
Neuronetics, Inc. 115.83 Million USD 88.104%
Star Equity Holdings, Inc. 86.97 Million USD 84.157%
Star Equity Holdings, Inc. 86.97 Million USD 84.157%
Trinity Biotech plc 59.43 Million USD 76.817%
Twist Bioscience Corporation 776.4 Million USD 98.225%
Exagen Inc. 56.94 Million USD 75.803%